Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) Invested Capital (2021 - 2025)

Praxis Precision Medicines has reported Invested Capital over the past 5 years, most recently at $878.1 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 97.13% year-over-year to $878.1 million; the TTM value through Dec 2025 reached $878.1 million, up 97.13%, while the annual FY2025 figure was $878.1 million, 97.13% up from the prior year.
  • Invested Capital for Q4 2025 was $878.1 million at Praxis Precision Medicines, up from $343.5 million in the prior quarter.
  • Over five years, Invested Capital peaked at $878.1 million in Q4 2025 and troughed at $64.5 million in Q1 2023.
  • A 5-year average of $272.4 million and a median of $229.7 million in 2024 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: crashed 69.66% in 2022 and later surged 539.38% in 2024.
  • Year by year, Invested Capital stood at $250.8 million in 2021, then crashed by 69.66% to $76.1 million in 2022, then decreased by 8.46% to $69.7 million in 2023, then surged by 539.38% to $445.4 million in 2024, then skyrocketed by 97.13% to $878.1 million in 2025.
  • Business Quant data shows Invested Capital for PRAX at $878.1 million in Q4 2025, $343.5 million in Q3 2025, and $404.2 million in Q2 2025.